Skip to main content

Showing results for Precision Health

Pediatric researchers receive two new grants to support work based on Tyler Trent's tumor cells

Two new grants supporting osteosarcoma research have been funded at IU School of Medicine, building on work that has been previously established based on Tyler Trent’s tumor cells. Karen E. Pollok, PhD, is the lead researcher for both of these grants, including $1.9 million from the U.S. Department of Defense and $50,000 from the Sarcoma Foundation of America.

Anna Carrera  |  Nov 28, 2022

Jennifer Marsh named first Director of Quality Assurance at IU School of Medicine

Jennifer Marsh has been named as the first Director of Quality Assurance for Research Affairs at Indiana University School of Medicine. Marsh is tasked with establishing a consistent approach to quality across IU School of Medicine, leading to a unified quality system focused on best practices and continuous improvement.

IU School of Medicine  |  Sep 02, 2022

Advocating for those left behind in research

When it comes to academic research, credit for the effort nearly always goes to an MD, PhD or RN. However, rarely do stories or news releases bring to light the empowering work and contributions that staff and members of the community make within the world of research.

Sonder Collins  |  Aug 16, 2022

Tyler Trent Foundation supports research with donation

Tyler Trent’s parents presented a check for $25,000 to Riley Children’s Foundation Tyler Trent Cancer Research Endowment on June 27 in front of the Herman B Wells Center on the IU School of Medicine campus. This money was donated on behalf of the Tyler Trent Foundation, which is dedicated to continuing Tyler’s mission to support pediatric cancer research and honor his memory. The money donated was raised at the inaugural Tee off for Tyler charity golf outing in 2021.

New research predicts opportunities for increased survival in pancreatic cancer

Pancreatic cancer is relatively rare when compared to other cancers, but still the third leading cause of cancer death in the U.S. with one of the lowest survival rates of any cancers. For that reason, much of pancreatic cancer research is dedicated to treating this deadly kind of cancer, including some work being done in the Liu Laboratory for Computational Genomics.

IU School of Medicine  |  Jul 05, 2022

Diagnostic event helps dozens

Members of the IU School of Medicine community offered up their patient care and pathology skills at the annual See, Test and Treat event, hosted in Indianapolis by the College of American Pathologists (CAP) Foundation.

See, Test and Treat events take place across the country and provide essential medical services to dozens of patients, free of charge, thanks to grant funding from CAP.

Caitlin VanOverberghe  |  Jun 17, 2022

Undiagnosed Rare Disease Clinic uses tech and teamwork to solve medical mysteries

Established in January 2020 through a grant from IU’s Precision Health Initiative, the Undiagnosed Rare Disease Clinic uses team science to sleuth out medical mysteries stemming from genetic code errors.

Laura Gates  |  Feb 25, 2022

October Research Update

Read the October Research update from Executive Associate Dean Tatiana Foroud, PhD.

Tatiana Foroud, PhD  |  Nov 16, 2021

Third IU Precision Health Initiative webinar focuses on multiple myeloma progress

The third IU Grand Challenges webinar about the Precision Health Initiative (PHI) took place in October, focusing on progress in studying and treating multiple myeloma, which is a cancer of the plasma cells in blood. This webinar featured Rafat Abonour, MD, who leads the IU Precision Health Initiative multiple myeloma disease research team, as well as Dorothy Frapwell, a multiple myeloma patient and retired IU general counsel. IU Vice President for Research Fred Cate served as the event’s host.

Anna Carrera  |  Nov 11, 2021

Single-cell Graph Convolutional Network allows for rapid knowledge transfer

An IU School of Medicine researcher developed a graph artificial intelligence model for single cell omics data analysis. Jing Su, PhD, is one of the corresponding authors of a Nature Communications publication about the single-cell Graph Convolutional Network (scGCN), which can help researchers transfer knowledge across different studies and datasets. scGCN software is currently available for researchers to download and use.

Anna Carrera  |  Nov 09, 2021